Dignity Sciences Ltd. – Trademark Portfolio

Entity Type: 99

Dignity Sciences Ltd. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. The owner is based in Dublin 18.

Trintech Building, 3rd Floor

South County Business Park, Leopardstown

Dublin 18 , IE

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DS
DS
Abandoned 2015
DS
DS
Cancelled 2015
DIGNICOS
DIGNICOS
Cancelled 2013
OMETHIC
OMETHIC
Cancelled 2013
EPADILIN
EPADILIN
Cancelled 2013
GALEPA
GALEPA
Cancelled 2013

Trademark Classifications

Dignity Sciences Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (5 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Dignity Sciences Ltd. have?

Dignity Sciences Ltd. has 9 U.S. trademarks filed with the USPTO.

What trademark classes does Dignity Sciences Ltd. file in?

Dignity Sciences Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Dignity Sciences Ltd.'s trademark registration success rate?

Dignity Sciences Ltd. has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.